Reply to Vogenthaler [2]

Clinical Infectious Diseases

Volumn 44, Issue 10, 2007, Pages 1387-1388

  Sungkanuparph, Somnuek ^a   Manosuthi, Weerawat ^b   Kiertiburanakul, Sasisopin ^a   Chantratita, Wasun ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE;

ANTIVIRAL ACTIVITY; DRUG EXPOSURE; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MONOTHERAPY; PRIORITY JOURNAL; TREATMENT FAILURE;

EID: 34248199470     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516611     Document Type: Letter

References (8)

1. Vogenthaler N. Lamivudine and second-line antiretroviral regimens [letter]. Clin Infect Dis 2007; 44:1387 (in this issue).
2. Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Piyavong B, Chumpathat N, Chantratita W. Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails. Clin Infect Dis 2007; 44:447-52.
3. Wei X, Liang C, Gotte M, Wainberg MA. The M184V mutation in HIV-1 reverse transcriptase reduces the restoration of wild-type replication by attenuated viruses. AIDS 2002; 16: 2391-8.
4. Campbell TB, Shulman NS, Johnson SC, et al. Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection. Clin Infect Dis 2005; 41:236-42.
5. Castagna A, Danise A, Menzo S, et al. Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study). AIDS 2006; 20:795-803.
6. Hammer SM, Saag MS, Schechter M, et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. International AIDS Society-USA panel. JAMA 2006; 296:827-43.
7. US Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents, October 10, 2006. Available at: http://aidsinfo.nih.gov/ContentFiles/Adultand AdolescentGL.pdf. Accessed 10 January 2007.
8. Fox Z, Dragsted UB, Gerstoft J, et al. A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trial. The COLATE study group. Antivir Ther 2006; 11:761-70.